argonaute rna
Lead Asset:
• Safe and effective new drug for residual risk of cardiometabolic disease
• Globally, 450 million live with ASCVD and each year 20 million die from ASCVD
• Most are preventable
Bispecific siRNA enters the cell as a monomer, splitting into individual siRNAs in endosome, followed by target mRNA cleavage and reduction of target gene expression.
